NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Above Foods Ingredients Inc. ("Above Food" or the "Company") (NASDAQ:ABVE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Above Food and certain of its […]
NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ramaco Resources, Inc. ("Ramaco" or the "Company") (NASDAQ:METC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ramaco and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ETHZilla Corporation ("ETHZilla" or the "Company") (NASDAQ:ETHZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ETHZilla and certain of its officers and/or directors have
NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Cogent Communications Holdings, Inc. ("Cogent" or the "Company") (NASDAQ:CCOI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Cogent and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Charming Medical Limited ("Charming Medical" or the "Company")(NASDAQ:MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Charming Medical and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC Therapeutics" or the "Company") (NYSE:ADCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ADC Therapeutics and certain of its officers
NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ:VTYX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ventyx and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Baidu, Inc. ("Baidu" or the "Company") (NASDAQ:BIDU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Baidu and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Caledonia Mining Corporation Plc ("Caledonia Mining" or the "Company") (NYSE:CMCL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Caledonia Mining and certain of
NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc("Waldencast" or the "Company") (NASDAQ:WALD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Waldencast and certain of its officers and/or directors have